EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal

Kamis, 18 Juni 2020 | 17:47 WIB
EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal
[ILUSTRASI. Small bottles labeled with a 'Vaccine COVID-19' sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration]
Reporter: Sumber: Reuters | Editor: Narita Indrastiti

KONTAN.CO.ID - BRUSSELS (Reuters). The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters.

The move would be the first arranged by the European Union executive since it was mandated last week by the 27 EU national governments to use an emergency fund with more than 2 billion euros ($2.3 billion) available to reach advance purchase or call-option deals with up to six vaccine makers.

The Commission’s deal with the U.S. firm Johnson & Johnson is “in the pipeline”, a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.

A second EU source said the Commission had a call with Johnson & Johnson on Tuesday over the possible agreement on its potential vaccine.

A Commission spokesman had no comment. Johnson & Johnson was not immediately available for comment outside U.S. business hours.

It was unclear whether any deal would involve an advance purchase of the vaccine in testing, or an option to buy it.

Johnson & Johnson plans next month to start human clinical trials for its experimental vaccine against the highly contagious coronavirus, which has infected more than 8.36 million people worldwide, with 447,985 deaths.

Germany, France, Italy and the Netherlands said last week they had acquired 400 million potential vaccine doses, in principle available to all member states, from British drugmaker AstraZeneca, which is developing a COVID-19 shot in conjunction with Oxford University.

AstraZeneca signed a similar deal in May with the United States.

The health official from an EU state said the EU deal with Johnson & Johnson could be announced as early as next week, but cautioned that it might take a little longer to finalise, and there were still chances it might not be struck at all.

EU decision-making procedures pose a sticking point for the potential deal, with member states still in talks over the establishment of a steering board for vaccine negotiations with drugmakers, officials told Reuters.

They said that under a draft plan devised by the EU Commission, which is still to be approved by EU governments, a green light from just four member states would be enough to start formal EU talks with a drugmaker.

But, underlining the urgency of securing a vaccine for the EU’s 450 million population, the Commission had already begun talks with Johnson & Johnson even before the steering board has been agreed.

By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.

But the risk is justified by the need to secure enough doses for the EU population in the global race for an effective vaccine, EU officials say.

Bagikan

Berita Terbaru

Terdorong Sentimen Positif Domestik, IHSG Menguat Dalam Sepekan
| Sabtu, 12 Juli 2025 | 11:30 WIB

Terdorong Sentimen Positif Domestik, IHSG Menguat Dalam Sepekan

Di akhir pekan perdagangan saham di Bursa Efek Indonesia (BEI), IHSG menclok di 7.047,43, menguat 2,65% dalam sepekan. 

Sudah Penuhi Kewajiban, BEI Cabut Suspensi Saham Kimia Farma (KAEF)
| Sabtu, 12 Juli 2025 | 11:24 WIB

Sudah Penuhi Kewajiban, BEI Cabut Suspensi Saham Kimia Farma (KAEF)

Sejak sesi pertama perdagangan saham di BEI kemarin, saham emiten farmasi pelat merah tersebut sudah kembali diperdagangkan.

Trump Tetap Patok Tarif 32%, Indonesia Patut Ikuti Langkah China Menjaring Mitra Baru
| Sabtu, 12 Juli 2025 | 10:00 WIB

Trump Tetap Patok Tarif 32%, Indonesia Patut Ikuti Langkah China Menjaring Mitra Baru

Indonesia juga mesti memaksimalkan penggunaan LCS dan BCSA untuk mengurangi ketergantungan terhadap dolar AS.

Profit 26,02% Setahun: Harga Emas Antam Hari Ini Menguat (12 Juli 2025)
| Sabtu, 12 Juli 2025 | 09:19 WIB

Profit 26,02% Setahun: Harga Emas Antam Hari Ini Menguat (12 Juli 2025)

Harga emas batangan Antam 24 karat hari ini 11 Juli 2025 di Logammulia.com Rp 1.919.000 per gram, tapi harga buyback Rp 1.763.000 per gram.

Menengok Aksi Eks CEO SMAR, Borong Total 131,95 Juta Saham NSSS Sejak Maret 2025
| Sabtu, 12 Juli 2025 | 09:00 WIB

Menengok Aksi Eks CEO SMAR, Borong Total 131,95 Juta Saham NSSS Sejak Maret 2025

Akumulasi saham PT Nusantara Sawit Sejahtera Tbk (NSSS) yang teranyar per tanggal 8 Juli 2025.melibatkan 38.420.600 saham. 

Pembiayaan Multifinance ke Sektor Produktif Menantang
| Sabtu, 12 Juli 2025 | 08:25 WIB

Pembiayaan Multifinance ke Sektor Produktif Menantang

Pembiayaan sejumlah perusahaan multifinance sektor produktif masih jauh dibawah target yang dicanangkan OJK sekitar 46%-48% ​

Rasio NPL Perbankan Masih Berpotensi Meningkat
| Sabtu, 12 Juli 2025 | 08:05 WIB

Rasio NPL Perbankan Masih Berpotensi Meningkat

NPL perbankan pada Mei 2025 sebesar 2,29% secara tahunan atau year on year (YoY), naik dari 2,24% pada April dan 2,08% pada Desember 2024.​

Menakar Prospek Harga Emas dan Efeknya ke Kinerja PT Hartadinata Abadi Tbk (HRTA)
| Sabtu, 12 Juli 2025 | 08:00 WIB

Menakar Prospek Harga Emas dan Efeknya ke Kinerja PT Hartadinata Abadi Tbk (HRTA)

Konsumsi emas di Indonesia hanya sekitar 0,17 gram per kapita, lebih rendah dibanding Malaysia yang mencapai 0,54 gram per kapita.

Kredit Menganggur Semakin Menumpuk
| Sabtu, 12 Juli 2025 | 07:30 WIB

Kredit Menganggur Semakin Menumpuk

Banyak korporasi belum memanfaatkan fasilitas kredit yang telah disetujui bank, membuat angka kredit menganggur terus meningkat.​

Saham Dengan Dividend Yield Tinggi dan Laba yang Bertumbuh
| Sabtu, 12 Juli 2025 | 07:18 WIB

Saham Dengan Dividend Yield Tinggi dan Laba yang Bertumbuh

Investor perlu memperhatikan kenaikan harga sebelum pengumuman dividen hingga sesaat sebelum membeli serta membandingkan dengan nominal dividen

INDEKS BERITA

Terpopuler